Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #501 to #550.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Platelet-derived growth factor (2 revisions)
- Clonogenic survival (2 revisions)
- Projected dose (2 revisions)
- Radionuclides of natural origin (2 revisions)
- Recovery (cellular or tissue) (2 revisions)
- Disposal (2 revisions)
- Dose criteria (2 revisions)
- Retrievability (2 revisions)
- Immune system (2 revisions)
- Environmental exposure (2 revisions)
- Institutional control (2 revisions)
- Exempt waste (2 revisions)
- Stakeholder (2 revisions)
- Tachycardia (2 revisions)
- Adaptive response (2 revisions)
- Tissue equivalent material (2 revisions)
- Alveolar-interstitial region (2 revisions)
- Myocardial stress test (2 revisions)
- Autoimmune disease (2 revisions)
- Oversight (2 revisions)
- ICRP Publication 118 (2 revisions)
- Cardiac valve diseases (2 revisions)
- Co-expertise (2 revisions)
- Connective tissue (2 revisions)
- Radiation safety officer (2 revisions)
- DRL process (2 revisions)
- Radioresponsiveness (2 revisions)
- Recovery responder (2 revisions)
- Reversibility (2 revisions)
- In vivo radiobioassay (2 revisions)
- Environmental radiation protection (2 revisions)
- Solar particle event (2 revisions)
- Exemption level (2 revisions)
- Worker (2 revisions)
- Nuclear track detectors (2 revisions)
- Protection strategy (2 revisions)
- Consequential late effects (2 revisions)
- Radiation source (2 revisions)
- Radiosensitiser (2 revisions)
- Rehabilitation of living conditions (2 revisions)
- Right to know (2 revisions)
- Effective dose equivalent (2 revisions)
- Incidence (2 revisions)
- Solar wind (2 revisions)
- Existing exposure situation (2 revisions)
- Target tissue (2 revisions)
- Gastroschisis (2 revisions)
- Measuring and Reducing Radon Levels in your Home (2 revisions)
- Angiogenesis (2 revisions)
- Hyperbaric oxygen (2 revisions)
